Concepedia

Bridgitte Shen Lee

BS

Statistics

Publications

3

Citations

59

H-Index

3

Active since

2019

Affiliations

Sun Pharma (United States)(Current)

North Valley Eye Medical Group

Eye Care Associates

Florida Eye Microsurgical Institute

Hofstra University

Bridgitte Shen Lee is an author at Sun Pharma (United States) specializing in ocular disease, ocular tolerability, and dermatology.

ORCID

Publications per year

2019–2022

3

Publications

3

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies

Ranjan Malhotra, Douglas K. Devries, Jodi Luchs et al. · Cornea · 2019 · 31 citations · Full text

, , +17

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials

Robert Smyth-Medina, Josh Johnston, Douglas K. Devries et al. · Journal of Ocular Pharmacology and Therapeutics · 2019 · 18 citations

, , +13

Open-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension

Bridgitte Shen Lee, Ranjan Malhotra, Kenneth Sall et al. · Clinical ophthalmology · 2022 · 10 citations · Full text

, , +17

1–3 of 3